Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
about
A systematic approach for the diagnosis and treatment of idiopathic peptic ulcersHelicobacter pylori: friend or foe?H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective studyNon-Helicobacter pylori, non-NSAIDs peptic ulcers: a descriptive study on patients referred to Taleghani hospital with upper gastrointestinal bleeding.Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs.Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics.Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults.The Role of Helicobacter pylori and NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer.Precise role of H pylori in duodenal ulceration.High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-upLong-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori.Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.Giant duodenal ulcersIs Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence.Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in AsiaRole of dietary phospholipids and phytosterols in protection against peptic ulceration as shown by experiments on rats.The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling.
P2860
Q26782135-3B0434D6-C1FB-45A0-9C3F-4B37D05F543FQ26992042-C71F55A4-B261-4586-A2F4-F8D0957E4AC5Q28217588-A3CC3F11-1F6E-4AE7-A036-75886EC62AF5Q33596424-64ABFC70-7AC5-4810-8933-0B2D7E9946AEQ35030551-CD431F0A-E080-461F-9CB7-77B4D607D8D4Q35045214-69340ECD-5CB3-43B4-9995-3B1E8B38DCD6Q35598340-657131A9-6032-446B-B4D5-84329F2AB10CQ36294219-E9DF9859-6A9B-435B-A088-843767BD31B3Q36638190-B40FA030-BC53-419F-8B4F-0F0F5DC62263Q36715131-C2F16889-2406-4472-8F5A-9B7C2616F4FCQ37213512-3F4DF53F-AF79-45D2-B968-DD3969A6BEC5Q37247773-A686A563-EB29-4258-AA08-850BD27ECE29Q37258431-6CE4F41D-D06A-4594-912A-3628AE430FCCQ38100785-A7D8C0C6-9BD1-428F-BE5F-80D240E99693Q38191568-4BA0A73D-BF34-4B40-ACB1-ED8EFA83F9CAQ38348749-35C21154-7A30-43C8-97FD-36AB0D500ED2Q43623343-31E4A4DD-95C1-4776-BD11-4E2B0B4C4BC9Q52663558-08127FFC-80A3-4518-9258-37743F86B669
P2860
Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Helicobacter pylori-negative d ...... d trial with 2-year follow-up.
@en
Helicobacter pylori-negative d ...... d trial with 2-year follow-up.
@nl
type
label
Helicobacter pylori-negative d ...... d trial with 2-year follow-up.
@en
Helicobacter pylori-negative d ...... d trial with 2-year follow-up.
@nl
prefLabel
Helicobacter pylori-negative d ...... d trial with 2-year follow-up.
@en
Helicobacter pylori-negative d ...... d trial with 2-year follow-up.
@nl
P2093
P2860
P1476
Helicobacter pylori-negative d ...... d trial with 2-year follow-up.
@en
P2093
Danish Ulcer Study Group
P S Teglbjaerg
P2860
P304
P356
10.1111/J.1572-0241.2001.03774.X
P407
P577
2001-05-01T00:00:00Z